[PHARMA] QoQ Quarter Result on 30-Sep-2021 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Sep-2021 [#3]
Profit Trend
QoQ- 263.65%
YoY- 3355.96%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 761,102 962,174 711,718 2,132,675 1,177,123 793,499 634,583 12.92%
PBT 4,521 37,439 125,088 98,219 22,244 31,524 -13,506 -
Tax -3,607 -8,583 -39,923 -47,895 -8,356 -8,696 6,459 -
NP 914 28,856 85,165 50,324 13,888 22,828 -7,047 -
-
NP to SH 722 27,734 85,475 49,835 13,704 23,136 -6,331 -
-
Tax Rate 79.78% 22.93% 31.92% 48.76% 37.57% 27.59% - -
Total Cost 760,188 933,318 626,553 2,082,351 1,163,235 770,671 641,630 12.00%
-
Net Worth 406,087 413,947 450,411 391,428 357,275 355,919 337,298 13.20%
Dividend
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Div 6,549 10,479 65,466 26,182 19,630 10,468 2,614 84.77%
Div Payout % 907.17% 37.79% 76.59% 52.54% 143.25% 45.25% 0.00% -
Equity
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Net Worth 406,087 413,947 450,411 391,428 357,275 355,919 337,298 13.20%
NOSH 1,309,126 1,309,126 1,309,336 1,309,126 261,991 261,705 261,705 193.35%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 0.12% 3.00% 11.97% 2.36% 1.18% 2.88% -1.11% -
ROE 0.18% 6.70% 18.98% 12.73% 3.84% 6.50% -1.88% -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 58.10 73.45 54.36 162.91 89.95 303.20 242.70 -61.54%
EPS 0.06 2.12 6.53 3.81 1.05 8.84 -2.42 -
DPS 0.50 0.80 5.00 2.00 1.50 4.00 1.00 -37.08%
NAPS 0.31 0.316 0.344 0.299 0.273 1.36 1.29 -61.44%
Adjusted Per Share Value based on latest NOSH - 1,309,126
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 52.81 66.76 49.38 147.97 81.67 55.06 44.03 12.92%
EPS 0.05 1.92 5.93 3.46 0.95 1.61 -0.44 -
DPS 0.45 0.73 4.54 1.82 1.36 0.73 0.18 84.51%
NAPS 0.2818 0.2872 0.3125 0.2716 0.2479 0.247 0.234 13.23%
Price Multiplier on Financial Quarter End Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 -
Price 0.595 0.755 0.74 0.835 5.29 3.26 5.00 -
P/RPS 1.02 1.03 1.36 0.51 5.88 1.08 2.06 -37.49%
P/EPS 1,079.54 35.66 11.34 21.93 505.18 36.88 -206.50 -
EY 0.09 2.80 8.82 4.56 0.20 2.71 -0.48 -
DY 0.84 1.06 6.76 2.40 0.28 1.23 0.20 161.00%
P/NAPS 1.92 2.39 2.15 2.79 19.38 2.40 3.88 -37.51%
Price Multiplier on Announcement Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 19/08/22 20/05/22 17/02/22 19/11/21 20/08/21 21/05/21 17/03/21 -
Price 0.595 0.72 0.76 0.845 0.925 4.03 3.49 -
P/RPS 1.02 0.98 1.40 0.52 1.03 1.33 1.44 -20.58%
P/EPS 1,079.54 34.01 11.64 22.20 88.34 45.59 -144.14 -
EY 0.09 2.94 8.59 4.51 1.13 2.19 -0.69 -
DY 0.84 1.11 6.58 2.37 1.62 0.99 0.29 103.59%
P/NAPS 1.92 2.28 2.21 2.83 3.39 2.96 2.71 -20.57%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment